Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
$35.1M
Market Cap • 12/24/20241998
(26 years)
2013
(11 years ago)
NASDAQ
Listing Exchange
Newtown
Headquarters • PennsylvaniaPremium
...and much more!